Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01581125 · ClinicalTrials.gov registry record · NA
Sleep Duration Required to Restore Performance During Chronic Sleep Restriction
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01581125: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT01581125 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01581125, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to test the hypothesis that sleep and performance depend on length of time awake, length of time asleep, the amount of sleep over several sleep episodes, and circadian phase.
Primary Outcome
PVT metrics are reaction time. It is measured when the participants are awake during the inpatient portion of the protocol.
Interventions
- BEHAVIORAL Sleep:wake 1
- BEHAVIORAL Sleep:wake 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2012-04 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT01581125 record still lists
NCT01581125 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Sleep:wake 1 is the first listed.
NCT01581125 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01581125 about?
NCT01581125 is a clinical study titled "Sleep Duration Required to Restore Performance During Chronic Sleep Restriction". The purpose of this study is to test the hypothesis that sleep and performance depend on length of time awake, length of time asleep, the amount of sleep over several sleep episodes, and circadian phase.
What is the current status of trial NCT01581125?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2012-04. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01581125?
The interventions under investigation include: Sleep:wake 1 (BEHAVIORAL), Sleep:wake 2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT01581125?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01581125's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia